Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics

    Forecasted

    This grant supports research to improve how cardiotoxicity from cancer treatments is detected, monitored, and treated, aiming to inform FDA regulatory decisions.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Collaborations to Enhance Drug Development and Regulatory Science

    FDA grant supports collaborative projects to advance drug development, manufacturing, and regulatory science, focusing on safety, efficacy, and innovation.

    HHS-FDA$5,000,000Forecasted

    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

    This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.

    HHS-NIH11Forecasted Jun 4, 2027$150,000Forecasted

    Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

    Research grant to understand and treat long-term side effects of cancer therapy through mechanistic and clinical studies supporting therapeutic interventions.

    HHS-NIH11Due Feb 5, 2027

    Innovation in Regulatory Science

    Innovation in Regulatory Science supports academic investigators developing tools, standards, and approaches to strengthen regulatory decisions and protect human health and safety.

    Burroughs Wellcome FundDue Feb 11, 2027$500,000

    Promoting Cancer Surveillance Workforce, Education, and Data Use

    This cooperative agreement supports cancer registry workforce training, better surveillance data, and wider use of National Program of Cancer Registries data in research and public health decisions.

    HHS-CDC-NCCDPHPForecasted Mar 8, 2027$2,900,000Forecasted